ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 963,25
0,90%
Dow Jones
44 565,07
0,92%
DAX
21 475,14
0,27%
Brent Oil
77,615
0,37%
Bitcoin
105 337,50
1,31%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Tevogen Bio Holdings Inc (TVGN) Cours

Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc (TVGN)

NASDAQ
1,38
0,00
(0,00%)
Fermé 24 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,38
Prix Achat
1,38
Prix Vente
1,40
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,2556 Plage de 52 semaines 21,09
Cap du marché
241,571M
Clôture Veille
1,38
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 553 024
Actions en circulation
175 051 247
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-11 275,00
Bénéfice par action (BPA)
-0
Chiffre d'affairess
-
Bénéfice net
-67k

À propos de Tevogen Bio Holdings Inc

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

Secteur
Biological Pds,ex Diagnstics
Industrie
Blank Checks
Site Web
www.tevogen.com/
Siège social
Wilmington, Delaware, USA
Fondé
2024
Tevogen Bio Holdings Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker TVGN. Le dernier cours de clôture d'Tevogen Bio était de US$1,38. Au cours de la dernière année, les actions de Tevogen Bio ont été négociées dans une fourchette de prix de US$ 0,2556 à US$ 21,09.

Tevogen Bio compte actuellement 175 051 247 actions en circulation. La capitalisation boursière d'Tevogen Bio est de US$241,57 million. Tevogen Bio a un ratio cours/bénéfice (ratio PE) de -11275.00.

TVGN Dernières nouvelles

Plus de nouvelles

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

il y a 8 heures
GlobeNewswire Inc.

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies...

26 Décembre 2024
GlobeNewswire Inc.

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

23 Décembre 2024
GlobeNewswire Inc.

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

19 Décembre 2024
GlobeNewswire Inc.

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

17 Décembre 2024
GlobeNewswire Inc.

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

10 Décembre 2024
GlobeNewswire Inc.

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech...

05 Décembre 2024
GlobeNewswire Inc.

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

26 Novembre 2024
GlobeNewswire Inc.

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

21 Novembre 2024
GlobeNewswire Inc.

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023...

19 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.1512.19512195121.231.381.2058753601.31784059CS
40.3432.69230769231.041.570.989114423821.28444724CS
12-1.08-43.90243902442.462.63530.856525530241.39000402CS
260.6589.04109589040.733.090.255686694311.53876131CS
52-2.72-66.34146341464.121.090.255649478051.54883063CS
156-2.72-66.34146341464.121.090.255649478051.54883063CS
260-2.72-66.34146341464.121.090.255649478051.54883063CS

TVGN - Frequently Asked Questions (FAQ)

What is the current Tevogen Bio share price?
The current share price of Tevogen Bio is US$ 1,38
How many Tevogen Bio shares are in issue?
Tevogen Bio has 175 051 247 shares in issue
What is the market cap of Tevogen Bio?
The market capitalisation of Tevogen Bio is USD 241,57M
What is the 1 year trading range for Tevogen Bio share price?
Tevogen Bio has traded in the range of US$ 0,2556 to US$ 21,09 during the past year
What is the PE ratio of Tevogen Bio?
The price to earnings ratio of Tevogen Bio is -11,28k
What is the reporting currency for Tevogen Bio?
Tevogen Bio reports financial results in USD
What is the latest annual profit for Tevogen Bio?
The latest annual profit of Tevogen Bio is USD -67k
What is the registered address of Tevogen Bio?
The registered address for Tevogen Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tevogen Bio website address?
The website address for Tevogen Bio is www.tevogen.com/
Which industry sector does Tevogen Bio operate in?
Tevogen Bio operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 17,03
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,26
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,03
(0,00%)
0
AACGATA Creativity Global
US$ 0,9128
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,03
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,26
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,03
(0,00%)
0
AACGATA Creativity Global
US$ 0,9128
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,03
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,26
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,03
(0,00%)
0
AACGATA Creativity Global
US$ 0,9128
(0,00%)
0

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
TVGN
Tevogen Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés